[DPHARMA] QoQ TTM Result on 30-Sep-2015 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
24-Nov-2015
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2015
Quarter
30-Sep-2015 [#3]
Profit Trend
QoQ- -0.14%
YoY- 2.05%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Revenue 327,738 304,911 271,040 232,663 197,750 182,065 176,961 50.86%
PBT 46,824 47,508 49,765 46,157 45,813 47,513 46,490 0.47%
Tax -11,087 -9,864 -10,980 -8,786 -8,393 -8,428 -8,009 24.23%
NP 35,737 37,644 38,785 37,371 37,420 39,085 38,481 -4.81%
-
NP to SH 36,314 37,659 38,785 34,569 34,618 36,283 35,679 1.18%
-
Tax Rate 23.68% 20.76% 22.06% 19.04% 18.32% 17.74% 17.23% -
Total Cost 292,001 267,267 232,255 195,292 160,330 142,980 138,480 64.51%
-
Net Worth 510,978 457,740 270,323 268,530 189,815 205,045 192,951 91.52%
Dividend
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Div 8,084 5,682 5,682 25,710 25,710 25,682 25,682 -53.75%
Div Payout % 22.26% 15.09% 14.65% 74.38% 74.27% 70.79% 71.98% -
Equity
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Net Worth 510,978 457,740 270,323 268,530 189,815 205,045 192,951 91.52%
NOSH 278,959 278,959 278,959 278,959 139,570 139,486 138,813 59.31%
Ratio Analysis
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
NP Margin 10.90% 12.35% 14.31% 16.06% 18.92% 21.47% 21.75% -
ROE 7.11% 8.23% 14.35% 12.87% 18.24% 17.70% 18.49% -
Per Share
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
RPS 102.62 109.24 162.43 139.50 141.68 130.52 127.48 -13.47%
EPS 11.37 13.49 23.24 20.73 24.80 26.01 25.70 -41.96%
DPS 2.53 2.04 3.41 15.42 18.50 18.50 18.50 -73.48%
NAPS 1.60 1.64 1.62 1.61 1.36 1.47 1.39 9.84%
Adjusted Per Share Value based on latest NOSH - 278,959
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
RPS 34.07 31.70 28.18 24.19 20.56 18.93 18.40 50.84%
EPS 3.78 3.91 4.03 3.59 3.60 3.77 3.71 1.25%
DPS 0.84 0.59 0.59 2.67 2.67 2.67 2.67 -53.77%
NAPS 0.5312 0.4759 0.281 0.2792 0.1973 0.2132 0.2006 91.51%
Price Multiplier on Financial Quarter End Date
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Date 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 -
Price 2.04 2.55 2.62 2.72 2.65 3.88 2.50 -
P/RPS 1.99 2.33 1.61 1.95 1.87 2.97 1.96 1.01%
P/EPS 17.94 18.90 11.27 13.12 10.68 14.92 9.73 50.41%
EY 5.57 5.29 8.87 7.62 9.36 6.70 10.28 -33.56%
DY 1.24 0.80 1.30 5.67 6.98 4.77 7.40 -69.63%
P/NAPS 1.28 1.55 1.62 1.69 1.95 2.64 1.80 -20.34%
Price Multiplier on Announcement Date
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Date 22/08/16 18/05/16 23/02/16 24/11/15 25/08/15 18/05/15 24/02/15 -
Price 2.14 2.40 2.61 2.70 2.40 3.90 2.92 -
P/RPS 2.09 2.20 1.61 1.94 1.69 2.99 2.29 -5.91%
P/EPS 18.82 17.79 11.23 13.03 9.68 14.99 11.36 40.05%
EY 5.31 5.62 8.91 7.68 10.33 6.67 8.80 -28.61%
DY 1.18 0.85 1.30 5.71 7.71 4.74 6.34 -67.43%
P/NAPS 1.34 1.46 1.61 1.68 1.76 2.65 2.10 -25.90%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment